Skip to main content
. 2023 Apr 1;14(5):874–879. doi: 10.7150/jca.67189

Table 3.

CIMAvax-EGF related adverse events. Most prevalent adverse events were injection site reactions including pain, erythema and induration.

Adverse Event Grade 1 Grade 2
No % No %
Pain in the site of injection 33 27.3 - -
Local erythema 12 10.9 - -
Nausea 5 4.5 - -
Induration
at the injection site
8 7.3 - -
Dizziness 5 4.5 - -
Vomiting 1 0.9 2 1.8
Fever 2 1.8 - -
Others 6 5.5 - -
All 72 67.9 2 1.8